Literature DB >> 31285382

Hypercalcemia and a "no observed adverse effect level" intake of vitamin D.

Reinhold Vieth1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31285382      PMCID： PMC6739067          DOI： 10.1503/cmaj.72512

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  15 in total

1.  Vitamin D poisoning by table sugar.

Authors:  Reinhold Vieth; Tanya R Pinto; Bajinder S Reen; Min M Wong
Journal:  Lancet       Date:  2002-02-23       Impact factor: 79.321

Review 2.  Risk assessment for vitamin D.

Authors:  John N Hathcock; Andrew Shao; Reinhold Vieth; Robert Heaney
Journal:  Am J Clin Nutr       Date:  2007-01       Impact factor: 7.045

3.  A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis.

Authors:  J M Burton; S Kimball; R Vieth; A Bar-Or; H-M Dosch; R Cheung; D Gagne; C D'Souza; M Ursell; P O'Connor
Journal:  Neurology       Date:  2010-04-28       Impact factor: 9.910

4.  The ratio of serum 24,25-dihydroxyvitamin D(3) to 25-hydroxyvitamin D(3) is predictive of 25-hydroxyvitamin D(3) response to vitamin D(3) supplementation.

Authors:  Dennis Wagner; Heather E Hanwell; Kareena Schnabl; Mehrdad Yazdanpanah; Samantha Kimball; Lei Fu; Gloria Sidhom; Dérick Rousseau; David E C Cole; Reinhold Vieth
Journal:  J Steroid Biochem Mol Biol       Date:  2011-05-13       Impact factor: 4.292

Review 5.  The Diagnosis, Differential Diagnosis, and Treatment of Sarcoidosis.

Authors:  Antje Prasse
Journal:  Dtsch Arztebl Int       Date:  2016-08-22       Impact factor: 5.594

Review 6.  Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety.

Authors:  R Vieth
Journal:  Am J Clin Nutr       Date:  1999-05       Impact factor: 7.045

7.  Safety of vitamin D3 in adults with multiple sclerosis.

Authors:  Samantha M Kimball; Melanie R Ursell; Paul O'Connor; Reinhold Vieth
Journal:  Am J Clin Nutr       Date:  2007-09       Impact factor: 7.045

8.  CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.

Authors:  A Molin; R Baudoin; M Kaufmann; J C Souberbielle; A Ryckewaert; M C Vantyghem; P Eckart; J Bacchetta; G Deschenes; G Kesler-Roussey; N Coudray; N Richard; M Wraich; Q Bonafiglia; A Tiulpakov; G Jones; M-L Kottler
Journal:  J Clin Endocrinol Metab       Date:  2015-07-27       Impact factor: 5.958

9.  Randomized clinical trial of vitamin D3 doses on prostatic vitamin D metabolite levels and ki67 labeling in prostate cancer patients.

Authors:  Dennis Wagner; Dominique Trudel; Theodorus Van der Kwast; Larisa Nonn; Angeline Antonio Giangreco; Doris Li; Andre Dias; Monique Cardoza; Sanda Laszlo; Karen Hersey; Laurence Klotz; Antonio Finelli; Neil Fleshner; Reinhold Vieth
Journal:  J Clin Endocrinol Metab       Date:  2013-03-05       Impact factor: 5.958

10.  Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis.

Authors:  Joost Smolders; Evelyn Peelen; Mariëlle Thewissen; Jan Willem Cohen Tervaert; Paul Menheere; Raymond Hupperts; Jan Damoiseaux
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.